<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03431233</url>
  </required_header>
  <id_info>
    <org_study_id>H-1705-091-855</org_study_id>
    <nct_id>NCT03431233</nct_id>
  </id_info>
  <brief_title>Effect of Premeal Protein-bar on Food Intake</brief_title>
  <official_title>An Exploratory Study of the Effect of Premeal Consumption of Protein-enriched, Dietary Fiber-fortified Cereal Bar on Food Intake in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to explore premeal protein-enriched bar effect in food intake in
      healthy subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty healthy subjects will be recruited. Every subject will be randomized in 6 groups and
      studied on 3 separate days in random order with 1 week intervals. These participants will
      consume protein enriched bar, commercial cereal bar, or water followed by a standardized diet
      (gimbap). For study outcomes, food intake, appetite and satiety (visual analog scale), plasma
      glucose, and satiety related hormone will be measured. Blood sampling will be done before 15
      min of breakeast, at the moment of start of breakfast (0 min), and then 30, 60, 90, 120 min.
      Plasma glucose levels, total/active GLP-1, ghrelin, total PYY will be measured.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Food intake</measure>
    <time_frame>120min</time_frame>
    <description>grams and caloric intake of standardized gimbap</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appetite (visual analogue scale : score 1 to 10)</measure>
    <time_frame>120min</time_frame>
    <description>(1: I am not hungry at all, 10: I have never been more hungry)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satiety (visual analogue scale : score 1 to 10)</measure>
    <time_frame>120min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma glucose (mmol/L)</measure>
    <time_frame>-15min, 0(breakfast), 30, 60, 90, 120 min</time_frame>
    <description>plasma level of glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma active/total GLP-1 (pmol/L)</measure>
    <time_frame>-15min, 0(breakfast), 30, 60, 90, 120 min</time_frame>
    <description>plasma level of active/total GLP-1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma active ghrelin (ng/ml)</measure>
    <time_frame>-15min, 0(breakfast), 30, 60, 90, 120 min</time_frame>
    <description>plasma level of active ghrelin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma total peptide YY (pg/ml)</measure>
    <time_frame>-15min, 0(breakfast), 30, 60, 90, 120 min</time_frame>
    <description>plasma level of peptide YY</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>protein enriched bar-&gt;commercial cereal bar-&gt;water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>protein enriched bar-&gt;water-&gt;commercial cereal bar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>commercial cereal bar-&gt;protein enriched bar-&gt;water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>commercial cereal bar-&gt;water-&gt;protein enriched bar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>water-&gt;protein enriched bar-&gt;commercial cereal bar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>water-&gt;commercial cereal bar-&gt;protein enriched bar</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein-enriched bar, commercial cereal bar, or water</intervention_name>
    <description>Protein enriched bar, commercial cereal bar, or water will be provided 15 minutes before breakfast.</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_label>Group 6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Inclusion Criteria:

               -  BMI 18.5~35 kg/m2

               -  Never diagnosed by diabetes

               -  Fasting plasma glucose &lt;=100mg/dl and HbA1c &lt;6.0%

          -  Exclusion Criteria:

               -  Those who diagnosed by Type 1 or Type 2 diabetes

               -  Allergy to wheat, flour, nuts, milk

               -  Pregnancy/lactation

               -  AST or ALT &gt;2.5 times of upper normal reference range

               -  eGFR &lt;30 mL/min/1.73m2

               -  Hb &lt;10g/dl

               -  History of GI surgery (except hemorrhoidectomy, appendectomy)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young Min Cho, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chang Ho Ahn, MD</last_name>
    <phone>82-2-2072-2263</phone>
    <email>ahncho@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Min Cho, MD, PHD</last_name>
      <phone>82-2-2072-1965</phone>
      <email>ymchomd@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2018</study_first_submitted>
  <study_first_submitted_qc>February 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2018</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Young Min Cho</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>protein-enriched bar</keyword>
  <keyword>food intake</keyword>
  <keyword>appetite</keyword>
  <keyword>satiety related hormones</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

